Debra Yu

Dr. Debra Yu has served as a member of the board of directors since April 2022. Dr. Yu currently serves as President and Chief Strategy Officer of LianBio, and previously served as LianBio’s President and Chief Business Officer. Dr. Yu has more than 30 years of healthcare industry experience in business development, alliance management, investment banking and capital markets. She has held senior positions at Pfizer in its Worldwide Business Development organization and Labrador Advisors, LLC, where she advised numerous partnerships and licensing transactions. Dr. Yu received a bachelor’s degree with high honors in molecular biology from Princeton University and earned a medical degree from Harvard Medical School.